Last update 01 Nov 2024
Martin Pharmaceuticals, Inc.

Martin Pharmaceuticals, Inc.

Startups
|
Holding Company|
2017|
New York, United States
|
< 10
|
www.martinpharma.com

Overview

Tags

Nervous System Diseases
Endocrinology and Metabolic Disease
Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
ACAA2(acetyl-CoA acyltransferase 2)1

Related

1
Drugs associated with Martin Pharmaceuticals, Inc.
Trimetazidine Hydrochloride
Target
ACAA2
Mechanism
ACAA2 inhibitors
Active Org.
Woolsey Pharmaceuticals, Inc.Woolsey Pharmaceuticals, Inc.Startup [+3]
Originator Org.
Les Laboratoires Servier SASLes Laboratoires Servier SAS
Active Indication
Angina Pectoris [+4]
Inactive Indication
Acute-On-Chronic Liver Failure
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
JP
First Approval Date31 Jan 1968
1
Clinical Trials associated with Martin Pharmaceuticals, Inc.
NCT03737448 / SuspendedPhase 1
A Phase 1b Open-Label Study Assessing the Pharmacokinetics, Tolerability, and Safety of Oral Trimetazidine in Subjects With Acute-on-Chronic Liver Failure
100 Clinical Results associated with Martin Pharmaceuticals, Inc.
Login to view more data
0 Patents (Medical) associated with Martin Pharmaceuticals, Inc.
Login to view more data
100 Deals associated with Martin Pharmaceuticals, Inc.
Login to view more data
100 Translational Medicine associated with Martin Pharmaceuticals, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Trimetazidine Hydrochloride
 ( ACAA2 )		Pulmonary Arterial Hypertension
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free